Child anxiety treatment in the context of COVID-19

Not Applicable

Completed

• Conditions: Anxiety problems in children aged 5-12; Mental and Behavioural Disorders

• Registration Number: ISRCTN12890382
• Lead Sponsor: niversity of Oxford

Brief Summary

2022 Protocol article in https://pubmed.ncbi.nlm.nih.gov/36384704/ (added 18/11/2022) 2024 Results article in https://doi.org/10.1016/s2215-0366(23)00429-7 (added 12/02/2024)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-10-23
• Study Completion: 2023-03-31
• Last Update Posted: 27 February 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 444

Inclusion Criteria

Child inclusion criteria:
1. Aged 5-12 years at intake
2. Primary problem is anxiety
3. Willing and able to assent

Parent/Carer inclusion criteria:
1. Has sufficient English language to complete measures/ access interventions
2. Family has access to the internet
3. Is willing and able to provide consent

Exclusion Criteria

Child exclusion criteria:
1. The child has co-morbid conditions that are likely to interfere with treatment delivery, (established autism spectrum condition/ learning disability, suicidal intent/ recurrent or potentially life-limiting self-harm)
2. The child is identified by social services due to child protection concerns

Parent/Carer exclusion criteria:
1. The parent has a significant intellectual impairment or severe mental health problem that is likely to interfere with treatment delivery
2. The parents are unable to access or understand the written English language materials necessary for the interventions

Study & Design

• Study Type: Interventional
• Study Design: Not specified